Ning Shen

January 25, 2023

Multi-Targeting Intranasal Nanoformulation as a Therapeutic for Alzheimer’s Disease

Abstract Melatonin, insulin, and Δ9-tetrahydrocannabinol (THC) have been shown to reverse cognitive deficits and attenuate neuropathologies in transgenic mouse models…

April 12, 2022

The Memory Benefit to Aged APP/PS1 Mice from Long-Term Intranasal Treatment of Low-Dose THC

Abstract THC has been used as a promising treatment approach for neurological disorders, but the highly psychoactive effects have largely…

March 2, 2022

Low-Dose Delta-9-Tetrahydrocannabinol as Beneficial Treatment for Aged APP/PS1 Mice

Abstract Studies on the effective and safe therapeutic dosage of delta-9-tetrahydrocannabinol (THC) for the treatment of Alzheimer’s disease (AD) have…